Select Bibliography

Filter by any of these (after searching):

Grant, B.

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 3 items

Combination Biologic Therapy as Initial Treatment for Follicular Lymphoma: Initial Results From CALGB 50701 - a Phase II Trial of Extended Induction Epratuzumab (anti-CD22) and Rituximab (anti-CD20)

Grant, B. , Leonard, J. P. , Johnson, J. L. , Kostakoglu, L. , Hsi, E. ... - ASH - Blood - 2010

Abstract - Primary - Primary - Lymphoma - CALGB-50701

BCL6 Expression and Treatment Delay Correlate with Adverse Outcome in Newly Diagnosed Primary CNS Lymphoma: Final Report of CALGB 50202 (Alliance)

Rubenstein, J. L. , Hsi, E. D. , Johnson, J. L. , Jung, S.-H. ... - ASH - ASH Annual Meeting Abstracts - 2012

Abstract - Secondary - Primary - Lymphoma - CALGB-50202

Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)

Rubenstein, J. L. , Hsi, E. D. , Johnson, J. L. , Jung, S.-H. ... - - J Clin Oncol - 2013

Manuscript - Primary - Primary - Lymphoma - CALGB-50202